ROIVANT SCIENCES

Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates. Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech and healthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.

#People #Financial #Event #Website #More

ROIVANT SCIENCES

Social Links:

Facebook

Twitter

Industry:

Biopharma Biotechnology Health Care Pharmaceutical Product Research

Founded:

2014-05-01

Address:

New York, New York, United States

Country:

United States

Website Url:

http://www.roivant.com

Total Employee:

501+

Status:

Active

Email Addresses:

[email protected]

Total Funding:

2.09 B USD

Technology used in webpage:

Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Global Site Tag Nginx Amazon

Current Advisors List

james-momtazee_image

James Momtazee Board of Director @ Roivant Sciences
Board_member
2021-10-01

Current Employees Featured

vivek-ramaswamy_image

Vivek Ramaswamy
Vivek Ramaswamy Founder and Executive Chairman @ Roivant Sciences
Founder and Executive Chairman
2014-01-01

mayukh-sukhatme_image

Mayukh Sukhatme
Mayukh Sukhatme Chief Investment Officer & President @ Roivant Sciences
Chief Investment Officer & President
2015-01-01

benjamin-zimmer_image

Benjamin Zimmer
Benjamin Zimmer President, Roivant Health @ Roivant Sciences
President, Roivant Health

frank-torti_image

Frank Torti
Frank Torti Vant Chair @ Roivant Sciences
Vant Chair
2018-01-01

matthew-gline_image

Matthew Gline
Matthew Gline Chief Executive Officer @ Roivant Sciences
Chief Executive Officer
2021-01-01

dan-rothman_image

Dan Rothman
Dan Rothman Chief Information Officer @ Roivant Sciences
Chief Information Officer
2017-04-01

not_available_image

Celine Chan
Celine Chan Chief Information Security Officer @ Roivant Sciences
Chief Information Security Officer
2022-04-01

eric-venker_image

Eric Venker
Eric Venker Chief Operating Officer @ Roivant Sciences
Chief Operating Officer
2018-01-01

drew-fromkin_image

Drew Fromkin
Drew Fromkin Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences) @ Roivant Sciences
Chief Executive Officer Proteovant, Vant Portfolio Operating Partner (Roivant Sciences)
2021-01-01

raheleh-hatami_image

Raheleh Hatami
Raheleh Hatami Associate, Investments @ Roivant Sciences
Associate, Investments
2018-04-01

Founder

vivek-ramaswamy_image

Vivek Ramaswamy

Stock Details

Company's stock symbol is NASDAQ:ROIV

Acquisitions List

Date	Company	Article	Price
2021-02-26	Silicon Therapeutics	Silicon Therapeutics acquired by Roivant Sciences	450 M USD

Investors List

eventide-asset-management_image

Investments List

Date	Company	Article	Money raised
2021-11-03	Medallion	Roivant Sciences investment in Series B - Medallion	30 M USD
2021-11-01	gen-t	Roivant Sciences investment in Pre Seed Round - gen-t	2 M USD
2021-08-02	Immunovant	Roivant Sciences investment in Post-IPO Equity - Immunovant	200 M USD
2020-10-08	Datavant	Roivant Sciences investment in Series B - Datavant	40 M USD
2018-04-30	Datavant	Roivant Sciences investment in Venture Round - Datavant	40.5 M USD
2017-10-02	Arbutus Biopharma	Roivant Sciences investment in Post-IPO Equity - Arbutus Biopharma	116.4 M USD

Key Employee Changes

Date	New article
2022-05-02	Roivant Appoints Chief Development Officer and Announces Multiple Collaborations in Targeted Protein Degradation

Official Site Inspections

http://www.roivant.com Semrush global rank: 836.93 K Semrush visits lastest month: 45.72 K

Host Informations
Whois Informations

Loading ...